oral glp 1 weight loss Patients taking an experimental GLP-1 drug lost significant and improved heart and metabolic risk factors in a large, worldwide phase 3 clinical trial led by Weill Cornell Medicine and other Wegovy Pill UK: First Oral
Description
There are no significant studies on microdosing GLP1s, but anecdotal reports suggest benefits like reduced appetite and weight loss at low doses
Health First Colorado (Medicaid) covers GLP-1 medications for obesity
The manufacturer suggests 4-6 weeks for initial effects and 12 weeks for full benefits
Tracking is what makes the second version possible
This is troubling, since those who discontinue early miss out on the long-term weight loss and health improvements that typically accrue after 3+ months of therapy
